Hydrogen sulfide-releasing anti-inflammatory drugs
- 31 October 2007
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 28 (10), 501-505
- https://doi.org/10.1016/j.tips.2007.09.003
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Enhanced activity of a hydrogen sulphide‐releasing derivative of mesalamine (ATB‐429) in a mouse model of colitisBritish Journal of Pharmacology, 2007
- Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivativeFree Radical Biology & Medicine, 2007
- Gastrointestinal Safety and Anti-Inflammatory Effects of a Hydrogen Sulfide–Releasing Diclofenac Derivative in the RatGastroenterology, 2007
- Hydrogen sulfide is an endogenous modulator of leukocyte‐mediated inflammationThe FASEB Journal, 2006
- Hydrogen sulfide inhibits nitric oxide production and nuclear factor-κB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharideFree Radical Biology & Medicine, 2006
- Evidence That Hydrogen Sulfide Is a Genotoxic AgentMolecular Cancer Research, 2006
- Inhibition of Hydrogen Sulfide Generation Contributes to Gastric Injury Caused by Anti-Inflammatory Nonsteroidal DrugsGastroenterology, 2005
- Hydrogen sulfide causes vanilloid receptor 1‐mediated neurogenic inflammation in the airwaysBritish Journal of Pharmacology, 2005
- Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain?Biochemical and Biophysical Research Communications, 2005
- Hydrogen Sulfide Induces Cyclic AMP and Modulates the NMDA ReceptorBiochemical and Biophysical Research Communications, 2000